Education
About Us
Working with TipRanks
Follow Us
Amgen Inc Insider Profile
11 Followers
Amgen Inc, Ten Percent Owner at Tetralogic Pharma, holds 990.17K shares in Tetralogic Pharma (Ticker: TLOG), holds ― shares in Unilife Corp (Ticker: UNISQ), holds 35.37M shares in Neumora Therapeutics, Inc. (Ticker: NMRA).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-24.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Amgen Inc holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 19, 2023 - Sep 19, 2024
Return:+6.20%
The most profitable trade made by Amgen Inc
Amgen Inc's Trading History
Tetralogic Pharma
Dec 17, 2013
Ten Percent Owner
Uninformative Buy
3.14M
$9.90K
Unilife Corp
―
―
―
―
BeiGene
Sep 13, 2021
Ten Percent Owner
Informative Buy
50.00M
$4.68B
Vigil Neuroscience Inc
Jan 11, 2022
Ten Percent Owner
Uninformative Buy
―
$8.02M
Neumora Therapeutics, Inc.
Sep 19, 2023
Ten Percent Owner
Uninformative Buy
―
$52.70M
List of latest transactions for each holding click on a transaction to see Amgen Inc's performance on stock
You May Also Like
Amgen Inc insider profile FAQ
What is the percentage of profitable transactions made by Amgen Inc?
The percentage of profitable transactions made by Amgen Inc is 50%.
What is the average return per transaction made by Amgen Inc?
The average return per transaction made by Amgen Inc is -24.50%.
What stocks does Amgen Inc hold?
Amgen Inc holds: TLOG, UNISQ, ONC, VIGL, NMRA stocks.
What was Amgen Inc’s latest transaction?
Amgen Inc latest transaction was an Uninformative Buy of $3.14M.
What was Amgen Inc's most profitable transaction?
Amgen Inc’s most profitable transaction was an Informative Buy of NMRA stock on September 19, 2023. The return on the trade was 6.20%.
What is Amgen Inc's role in Tetralogic Pharma?
Amgen Inc's role in Tetralogic Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.